Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
188-0551 in Plaque Psoriasis
NCT03065556Phase 2Completed
- Start
- Jan 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 188-0551 in plaque psoriasis. Started Jan 2017; status: completed.
02
Drugs
188-0551
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03065556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03065556.